ClinicalTrials.gg
Not yet recruitingNCT07845981MCT-MLTUpdated Sep 29, 2026

Multi-Component Training Versus Motor Learning Techniques in Adults With ADHD

An interventional study of Multi-Component Training and Motor Learning Techniques in Attention Deficit Hyperactivity Disorder, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This randomized clinical trial aims to compare the effects of multi-component training and motor learning techniques on attention, cognitive performance, and motor coordination in adults with Attention Deficit Hyperactivity Disorder (ADHD). ADHD in adults is associated with impairments in executive function, attention regulation, and motor coordination, which significantly impact daily functioning and quality of life. While pharmacological and behavioral therapies are commonly used, non-pharmacological interventions such as structured exercise and motor learning approaches have shown potential benefits.

A total of 44 participants aged 18-30 years with clinically diagnosed ADHD will be recruited and randomly allocated into two groups. Group A will receive multi-component training including aerobic, resistance, balance, and flexibility exercises, while Group B will receive motor learning techniques focusing on task-oriented and cognitive-motor dual-task training. Both interventions will be administered three times per week for eight weeks.

Outcome measures will include standardized tools assessing attention, executive function, and cognitive performance, including ADHD rating scales and cognitive assessments. Data will be analyzed pre- and post-intervention to determine within-group and between-group differences. This study aims to identify effective, non-pharmacological rehabilitation strategies for improving cognitive and motor outcomes in adults with ADHD.

Read the detailed description

Background and Rationale

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity, persisting into adulthood in a significant proportion of individuals. Adults with ADHD commonly experience deficits in executive function, attention, working memory, and motor coordination, leading to reduced occupational performance, impaired social relationships, and decreased quality of life.

Although pharmacological treatments such as stimulant medications are widely used, they may not be suitable for all individuals due to side effects, contraindications, or limited long-term effectiveness. Therefore, there is increasing interest in non-pharmacological interventions such as structured physical exercise and motor learning techniques, which may enhance neuroplasticity and improve cognitive and motor outcomes.

Multi-component training integrates aerobic, resistance, balance, and flexibility exercises and has been associated with improvements in executive function, attention, and emotional regulation. Motor learning techniques focus on task-oriented training, repetition, feedback, and cognitive-motor integration to improve coordination and functional performance. However, limited research has directly compared these two approaches in adults with ADHD.

Objective

To compare the effects of multi-component training and motor learning techniques on attention, cognitive performance, and motor coordination in adults with ADHD.

Study Design

This study will be a single-blind, randomized clinical trial.

Participants

A total of 44 participants aged 18-30 years with clinically diagnosed ADHD will be recruited using non-probability convenience sampling. Participants must meet inclusion criteria including confirmed ADHD diagnosis and ability to participate in moderate physical activity.

Randomization and Blinding

Participants will be randomly assigned to one of two groups using a computer-generated randomization method. Allocation will be concealed using sealed opaque envelopes. The outcome assessor will remain blinded to group allocation.

Interventions

Group A: Multi-Component Training

Participants will undergo a structured exercise program including:

Aerobic training (moderate intensity) Resistance training using light weights or bands Balance and flexibility exercises Sessions will be conducted three times per week for 8 weeks.

Group B: Motor Learning Techniques

Participants will receive:

Task-oriented motor training Cognitive-motor dual-task activities Feedback-based motor learning strategies Sessions will be conducted three times per week for 8 weeks. Outcome Measures

Primary and secondary outcomes will be assessed at baseline and post-intervention using standardized tools:

Adult ADHD Self-Report Scale (ASRS) Montreal Cognitive Assessment (MoCA) Conners' Adult ADHD Rating Scales (CAARS) Stroop Color and Word Test Trail Making Test (Parts A and B) Digit Span Test Behavior Rating Inventory of Executive Function (BRIEF-A) Data Analysis

Data will be analyzed using SPSS version 27. Descriptive statistics will summarize participant characteristics. Normality will be assessed using the Shapiro-Wilk test.

Within-group comparisons: Paired t-test or Wilcoxon signed-rank test Between-group comparisons: Independent t-test or Mann-Whitney U test Statistical significance set at p \< 0.05 Expected Outcome

This study is expected to determine whether multi-component training or motor learning techniques are more effective in improving attention, cognitive performance, and motor coordination in adults with ADHD. Findings may contribute to evidence-based, non-pharmacological rehabilitation strategies for ADHD management.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder

Keywords

  • Motor Training
  • Neurorehabilitation
  • Randomized Clinical trail
  • Attention Deficit Hyperactivity Disorder
  • Attention
  • Cognitive Performance
  • motor Learning Techniques
  • Multi-Component Training
03

In context

Attention Deficit Disorder with Hyperactivity

1,818 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 295 are open to participants now.

This study's planned enrollment of 44 is below the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,194 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female adults aged 18 to 30 years.
  • Clinically diagnosed with Attention Deficit Hyperactivity Disorder.
  • Adult ADHD Self-Report Scale score indicating ADHD symptoms.
  • score less than 26 out of 30.
  • Medically stable and able to participate in moderate physical activity.
  • Not currently participating in any other structured cognitive or physical intervention program.
  • Able to attend supervised sessions three times per week for 8 weeks.
  • Willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • History of systemic or neurological disorders.
  • Currently undergoing treatment for ADHD or participating in similar interventions.
  • Physical limitations preventing participation in physical activity.
  • Severe psychiatric conditions such as schizophrenia or bipolar disorder.
  • Uncontrolled cardiovascular conditions or medical to moderate physical activity.
  • Taking medications that significantly alter cognitive or motor performance unless stabilized for at least 3 months.
  • History of substance abuse within the past 12 months.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Multi-Component Training Group

    Participants in this group will receive multi-component training including warm-up, aerobic training, resistance training, balance and flexibility exercises, breathing exercises, and cool-down. Sessions will be conducted three times per week for 8 weeks, with each session lasting approximately 30-40 minutes.

    Behavioral: Multi-Component Training

  • Active comparator
    Motor Learning Techniques Group

    Participants in this group will receive motor learning techniques including warm-up, task-oriented training, cognitive-motor dual-task activities, feedback-based learning, and cool-down. Sessions will be conducted three times per week for 8 weeks, with each session lasting approximately 30-40 minutes.

    Behavioral: Motor Learning Techniques

Interventions

  • BehavioralMulti-Component Training

    Multi-component training will include warm-up, moderate-intensity aerobic exercise, resistance training using light weights or resistance bands, balance and flexibility exercises, breathing exercises, and cool-down. Sessions will be supervised three times per week for 8 weeks, with each session lasting approximately 30-40 minutes.

    Also known as: Exercise Training, Multicomponent Exercise Program

  • BehavioralMotor Learning Techniques

    Motor learning techniques will include warm-up, task-oriented functional motor activities, cognitive-motor dual-task exercises, feedback-based learning, and cool-down. Sessions will be supervised three times per week for 8 weeks, with each session lasting approximately 30-40 minutes.

    Also known as: Task-Oriented Training, Cognitive-Motor Dual-Task Training

06

What researchers measure

Primary outcomes

  1. Conners' Adult ADHD Rating Scale

    Adult ADHD symptom severity will be assessed using the Conners' Adult ADHD Rating Scales (CAARS).

    Time frame: 8 weeks of treatment (Pre & Post)

Secondary outcomes

  1. Purdue Pegboard Test

    Dominant-hand motor coordination and manual dexterity will be assessed using the Purdue Pegboard Test.

    Time frame: Baseline and immediately after completion of the 8-week intervention

  2. Trial Making Test

    Performance was assessed by noting the overall completion time for each segment in seconds

    Time frame: 8 weeks of intervention (Pre & Post)

07

Study locations

1 site
  • Shalamar Hospital and Ali Hospital
    Lahore, Punjab Province 54000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 3 months is below that.

Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 1, 2026
First posted
Sep 29, 2026
StartEst.
Sep 10, 2026
Primary completionEst.
Dec 10, 2026
CompletionEst.
Dec 10, 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07845981
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
Dec 10, 2026 (estimated)
Completion
Dec 10, 2026 (estimated)
Last update
Sep 29, 2026

Study contacts

Ambreen iqbal
Contact
iqbalambreen8@gmail.com
+92 322 7616154
Wajeeha Zia
Contact
wajeeha.zia@riphah.edu.pk
+92 323 450078
Wajeeha zia
principal investigator · Riphah International University Role

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion